| RS886043167 |
TECPR2
|
Health Risk |
Pathogenic |
— |
| RS886043170 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS886043172 |
ANO5
|
Health Risk |
Pathogenic/Likely pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS886043175 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS886043180 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS886043182 |
SMCHD1
|
Health Risk |
Pathogenic |
— |
| RS886043187 |
COL6A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS886043189 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS886043191 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS886043193 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS886043199 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to LMNA mutation, Congenital muscular dystrophy due to LMNA mutation |
| RS886043201 |
RAB3GAP1
|
Health Risk |
Pathogenic |
— |
| RS886043202 |
RAB3GAP1
|
Health Risk |
Pathogenic |
— |
| RS886043203 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Walker-Warburg congenital muscular dystrophy |
| RS886043213 |
FREM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fraser syndrome 2, Isolated cryptophthalmia |
| RS886043215 |
ERCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043219 |
FHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked myopathy with postural muscle atrophy, Cardiovascular phenotype |
| RS886043220 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS886043221 |
SGCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS886043222 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886043225 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043228 |
SGCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS886043231 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS886043233 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS886043234 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS886043236 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS886043237 |
GRIN2B
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS886043238 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886043239 |
CHRNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS886043240 |
PTPRQ
|
Health Risk |
Pathogenic |
— |
| RS886043241 |
POLG
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, Progressive sclerosing poliodystrophy |
| RS886043242 |
CLN3
|
Health Risk |
Pathogenic |
— |
| RS886043243 |
CAMTA1
|
Health Risk |
Likely pathogenic |
— |
| RS886043244 |
EPG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS886043247 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Neoplasm |
| RS886043248 |
BBS9
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS886043249 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS886043250 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS886043251 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043252 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS886043253 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS886043258 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS886043260 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Congenital muscular dystrophy due to LMNA mutation |
| RS886043262 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, Myofibrillar myopathy 3 |
| RS886043265 |
AGPAT2
|
Health Risk |
Pathogenic |
— |
| RS886043268 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS886043269 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043270 |
COL6A2
|
Health Risk |
Pathogenic |
— |
| RS886043279 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886043283 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043285 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS886043287 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS886043288 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886043291 |
COL6A1
|
Health Risk |
Pathogenic |
— |
| RS886043293 |
RPS6KA3
|
Health Risk |
Pathogenic |
— |
| RS886043294 |
UQCRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex III deficiency nuclear type 3, Mitochondrial complex III deficiency nuclear type 3 |
| RS886043295 |
DNAJC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS886043296 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS886043300 |
KRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS886043303 |
CEP290
|
Health Risk |
Pathogenic |
Blindness, Global developmental delay |
| RS886043307 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Walker-Warburg congenital muscular dystrophy |
| RS886043311 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS886043313 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS886043314 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS886043316 |
WDR35
|
Health Risk |
Pathogenic |
— |
| RS886043317 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS886043321 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043323 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043324 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS886043325 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043327 |
ANO5
|
Health Risk |
Pathogenic/Likely pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS886043328 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS886043330 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043332 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS886043333 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS886043337 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS886043340 |
OPA1
|
Health Risk |
Likely pathogenic |
Auditory neuropathy, Auditory neuropathy |
| RS886043341 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886043342 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS886043343 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS886043344 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS886043346 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS886043347 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Inborn genetic diseases |
| RS886043348 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886043349 |
MTHFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS886043350 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS886043351 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043354 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043356 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spondyloperipheral dysplasia, Stickler syndrome type 1 |
| RS886043360 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043361 |
ROR2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043364 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Inborn genetic diseases |
| RS886043366 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS886043368 |
IHH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043369 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS886043371 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS886043372 |
CHRNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043374 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS886043375 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS886043376 |
DMD
|
Health Risk |
Pathogenic |
— |